Global Cefazolin Sodium Market Size Analysis 2022, Top Regions, Key Players and Investments Opportunities Forecast to 2028

The global cefazolin sodium market is anticipated to grow at a significant CAGR 6% during the forecast period (2022-2028). Cefazolin sodium is used for the treatment of infections in the human body. This drug treats certain infections which are caused by bacteria in the body. Bacteria hits body parts such as skin, bone, joint, genital, blood, respiratory tract. Sometimes infections that are caused by bacteria in the urinary tract are also treated by cefazolin sodium. When surgery is done in any part of the body, there are chances of infection before or after the surgery. For this treatment, cefazolin sodium injections are given for a certain period to get rid of bacterial infections. These come under an umbrella term or class of infections known as cephalosporin antibiotics. Cefazolin sodium is given for certain penicillin-allergic patients with certain heart conditions. This drug prevents them from developing a heart valve infection in the body. Infection in newborn children is also prevented during the time of labor by using this drug.

The efficacy and safety of the cefazolin sodium drug in reducing infections is expected to drive the market during the forecast period. For instance, in Oct 2021, Sandoz International GmbH has completed its acquisition of taking over the cephalosporin business of GlaxoSmithKline Plc for $500 million. This acquisition has granted rights to Sandoz to acquire its major cephalosporin antibiotic tablet brands such as Zinnat, Zinacef, and Fortum. This however excludes certain rights on drugs that GlaxoSmithKline plc had earlier sold to the US, Australia, and Germany. Sandoz International Gmbh will not have rights in countries such as India, Pakistan, and China and also to certain brands in Japan. According to the company, GlaxoSmithKline Plc had received $150 million and an additional $350 million as milestone payment.

Some major players in the market include Pfizer Inc., Baxter International Inc., and Teva Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in Sept 2021, the Cephalosporin manufacturing plant which is based in Mehsana has been acquired by Lincoln Pharmaceuticals Ltd. and the company has further invested in the expansion of the plant to cater to the production of cephalosporin antibiotics. As per the company, this plant will be ready for commercial operations by end of Feb 2022. The company will manufacture all forms of antibiotics such as tablets, capsules, and injectables. After further approvals for some of the drugs, the company plans to export them in Africa, Latin America, and Southeast Asia.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Pfizer Inc., Baxter International Inc., and Teva Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cefazolin Sodium Market Report By Segment

By Treatment

• Surgery
• Infection

By End-User

• Hospital
• Clinic
• Other

Global Cefazolin Sodium Market Report By Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa